Browsing Tag
NYSE American
25 posts
Picard Medical can lift PMI’s quoted price 50-fold, but can it repair the balance sheet?
Picard Medical’s share consolidation could strengthen its quoted price and preserve market access, but investors still need evidence of improved equity, liquidity and commercial scale.
NUBURU closes $38m offering as Tekne acquisition and NYSE listing risks converge
NUBURU’s financing could advance its Tekne acquisition and eliminate US$16.75 million of debt, but investors face significant dilution and delisting uncertainty.
Exodus Movement (EXOD) restructures after receivership deal for Monavate and Baanx reshapes the group
Exodus Movement cuts 25 percent of its workforce to fund a payments pivot, but execution during Monavate and Baanx integration will decide the outcome.
Catheter Precision (VTAK) rallies 122% on new patents and Flyte 1,000 user milestone
Catheter Precision (VTAK) rallies 122% as two new patents and Flyte hits 1,000 users boost pivot story. Going concern warning still shadows the rally.
Could Idaho Copper’s NYSE American uplisting strengthen COPR’s critical minerals profile?
Find out how Idaho Copper’s expected NYSE American uplisting could affect COPR stock, CuMo project visibility and U.S. critical minerals supply.
Perfect Moment’s stock just lost its exchange shine, but is the OTCQB move a retreat or reset?
Find out how Perfect Moment’s OTCQB move changes the outlook for PMNT stock, investor access and its luxury growth strategy today!
Why BIG3 Basketball’s GRAF merger may become a test case for public sports ownership
Find out how BIG3 Basketball’s GRAF merger could reshape public sports investing as 3-on-3 basketball gains fresh market attention.
Vida Global closes $15m IPO as VIDA stock tests the market’s appetite for AI agent platforms
AI agent hype met micro-cap reality. Vida Global’s IPO gives VIDA stock public currency, but investors want proof before premium.
BW Industrial (BWGC) IPO heads to NYSE American May 27 after twice cutting price range
BWGC IPO has slipped twice and repriced lower. Two clients still drive 83% of revenue. What retail investors should track before the 27 May NYSE American debut.
Mayfair Gold Q1 loss widens as Fenn-Gib gold project moves deeper into execution phase
Mayfair Gold has cash, a PFS and a 2030 target. The harder test is whether Fenn-Gib can move from paper economics to mine execution.